"Melanoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Descriptor ID |
D008545
|
| MeSH Number(s) |
C04.557.465.625.650.510 C04.557.580.625.650.510 C04.557.665.510
|
| Concept/Terms |
Melanoma- Melanoma
- Melanomas
- Malignant Melanoma
- Malignant Melanomas
- Melanoma, Malignant
- Melanomas, Malignant
|
Below are MeSH descriptors whose meaning is more general than "Melanoma".
Below are MeSH descriptors whose meaning is more specific than "Melanoma".
This graph shows the total number of publications written about "Melanoma" by people in this website by year, and whether "Melanoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 1 | 5 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 0 | 3 |
| 1999 | 9 | 1 | 10 |
| 2000 | 5 | 0 | 5 |
| 2001 | 5 | 1 | 6 |
| 2002 | 5 | 2 | 7 |
| 2003 | 4 | 0 | 4 |
| 2004 | 9 | 1 | 10 |
| 2005 | 6 | 4 | 10 |
| 2006 | 12 | 0 | 12 |
| 2007 | 5 | 2 | 7 |
| 2008 | 10 | 2 | 12 |
| 2009 | 10 | 1 | 11 |
| 2010 | 9 | 2 | 11 |
| 2011 | 11 | 2 | 13 |
| 2012 | 18 | 2 | 20 |
| 2013 | 17 | 2 | 19 |
| 2014 | 14 | 2 | 16 |
| 2015 | 18 | 2 | 20 |
| 2016 | 17 | 0 | 17 |
| 2017 | 20 | 1 | 21 |
| 2018 | 17 | 0 | 17 |
| 2019 | 21 | 1 | 22 |
| 2020 | 15 | 2 | 17 |
| 2021 | 15 | 3 | 18 |
| 2022 | 11 | 0 | 11 |
| 2023 | 23 | 0 | 23 |
| 2024 | 14 | 2 | 16 |
| 2025 | 16 | 0 | 16 |
| 2026 | 9 | 1 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Melanoma" by people in Profiles.
-
Tumor-infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions. Cancer. 2026 Aug 01; 132(15):e70526.
-
Skin imaging techniques for melanoma detection: A scoping review of modalities, clinical viability, and deployment strategies. J Invest Dermatol. 2026 Jul; 146(7):1752-1769.e32.
-
Clinical Utility of Copy Number Abnormality Analysis in the Evaluation of Melanocytic Lesions for Diagnosis and Prognosis: An Evidence-Based Review from the Cancer Genomics Consortium Working Group for Melanocytic Lesions. Genes (Basel). 2026 Mar 18; 17(3).
-
The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors. Hum Pathol. 2026 Jun; 172:106103.
-
Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance). Cancer Immunol Res. 2026 Mar 04; 14(3):423-433.
-
Clonal dynamics shaped by diverse drug-tolerant persister states in melanoma resistance. Mol Cancer. 2026 Mar 03; 25(1).
-
Targeting Melanoma-Associated Fibroblasts to Overcome Cancer Stem Cell-Driven Drug Resistance. J Am Coll Surg. 2026 Apr 01; 242(4):761-771.
-
Current Trends in Melanocytic Lesions. Dermatol Clin. 2026 Apr; 44(2):183-190.
-
Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database. Ann Surg Oncol. 2026 May; 33(5):4011-4022.
-
IFN?-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma. Cancer Cell. 2026 Apr 13; 44(4):792-808.e9.